[PTCA with drug eluting stent. 90% fewer restenoses in high risk patients].
D015906:Angioplasty, Balloon, Coronary; D002986:Clinical Trials as Topic; D020099:Coated Materials, Biocompatible; D023903:Coronary Restenosis / Q000517:prevention & control*; D023921:Coronary Stenosis / Q000628:therapy*; D003925:Diabetic Angiopathies / Q000628:therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D012307:Risk Factors; D020123:Sirolimus / Q000008:administration & dosage*; D015607:Stents
D020099:Coated Materials, Biocompatible; D007166:Immunosuppressive Agents; D020123:Sirolimus